ReviewXIAP deficiency syndrome in humans
Introduction
In 2006, 12 boys of three non-related families were identified as carriers of deleterious mutations in XIAP leading to loss of XIAP protein expression and function. These boys all suffered from immunodeficiency and most of them had developed hemophagocytic lymphohistiocytosis (HLH) subsequently to Epstein–Barr Virus infection (also termed virus-associated hemophagocytic syndrome (VAHS)) [1]. Some boys had also hypogammaglobulinemia and two developed inflammatory bowel disease (IBD). The susceptibility to EBV infection that triggers HLH, and the hypogammaglobulinemia, were reminiscent of the clinical phenotypes associated with the X-linked lymphoproliferative (XLP) syndrome caused by mutations in the gene SH2D1A (also named SAP deficiency) [2]. Based on these clinical similarities, XIAP deficiency was defined as a second genetic cause of XLP and denoted as XLP type 2 (XLP-2), while SAP deficiency was termed XLP-1. Furthermore and interestingly enough, SH2D1A and XIAP are both localized in Xq25 in the same vicinity and are only separated by a region of 2 Mb containing a single gene. At that time, it was tempting to hypothetize that SH2D1A and XIAP could form a functional cluster. Since then, however, a growing body of evidence has suggested that XLP-1 and XLP-2 are non-functionally related diseases, even if they share some striking similarities at first sight. The most convincing common feature is HLH, also known as macrophage activation syndrome (MAS). HLH is a life-threatening immunodeficiency characterized by hyperinflammation caused by an uncontrolled and ineffective immune response, in which activated T lymphocytes and macrophages accumulate in organs, and produce massive amounts of pro-inflammatory cytokines, such as IFN-γ, TNF-α and IL-6, resulting in tissue damage and organ failure [3], [4]. HLH is triggered in most cases by infectious pathogens, in particular viruses.
Section snippets
Functions of XIAP
XIAP belongs to the Inhibitor of Apoptosis Protein (IAP) gene family and shares important functional and structural features with two other cellular IAPs, cIAP-1 and cIAP-2. It is composed of 3 BIR domains (Baculovirus Inhibitor of apoptosis Repeats), an Ubiquitin-associated domain (UBA), and a C-terminal RING domain which has E3 ubiquitin ligase activity. XIAP is ubiquitously expressed and its expression is significantly increased in cancer cells. Originally, the first function ascribed to
Mouse models of XIAP deficiency
Xiap-deficient mouse models have been developed, and the first characterization of these models did not reveal any obvious phenotype or abnormalities, in particular regarding apoptosis [28], [29]. However, the following recent studies reveal that Xiap-deficient mice have compromised immunity leading to decreased survival when infected with certain pathogens. Those include intracellular gram-negative and -positive bacteria, such as Listeria monocytogenes [30], Chlamydophilia pneumonia [31] and
Clinical features
Since its original discovery, more than 70 male patients from different countries have been diagnosed with an XLP-2/XIAP deficiency [1], [36], [37], [38], [39], [40]. XIAP deficiency is mostly a pediatric disease and boys can be affected very early in their life (during the first months) with symptoms which are especially severe – the younger the patient is. The most frequent clinical manifestations are HLH (54%), recurrent splenomegaly (57%) and IBD (26%). EBV is very often the trigger of HLH
Conclusion and perspectives
The recent findings revealing that XIAP (as well as cIAP-1 and cIAP-2) is an important player in innate immunity and in the negative regulation of inflammation provide new insights into the immunopathogenesis of XIAP deficiency in humans. These studies also open novel perspectives for the treatment of the XIAP deficiency or related diseases. TNF-α and IL-18 appear to be important cytokines associated with the disease, thus they may represent potential therapeutic targets for inflammation
Acknowledgements
S. L. is a senior scientist at the Centre National de la Recherche Scientifique-CNRS (France) and C.A. is an M.D./Ph.D. and was a fellowship recipient of the Fondation ARC pour la Recherche sur le Cancer. This work was supported by grants from INSERM, the Agence Nationale de la Recherche (ANR) (ANR-14-CE14-0028-01, ANR-2010-MIDI-005-02, ANR-10-IAHU-01 and ANR-08-MIEN-012-01), the Fondation ARC pour la Recherche sur le Cancer (France), the European Research Council (ERC-2009-AdG_20090506 n°
References (83)
- et al.
IAP proteins: regulators of cell migration and development
Curr Opin Cell Biol
(2012) - et al.
Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2
Immunity
(2009) - et al.
Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap−/− mice
Blood
(2014) - et al.
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mol Cell
(2008) - et al.
XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation
Cell Rep
(2014) - et al.
Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation
Immunity
(2012) - et al.
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner
Blood
(2014) - et al.
Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice
J Biol Chem
(2010) - et al.
Small-molecule SMAC mimetics as new cancer therapeutics
Pharmacol Ther
(2014) - et al.
Inhibitors of apoptosis proteins (IAPs) are required for effective T-cell expansion/survival during antiviral immunity in mice
Blood
(2014)
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
Blood
Two new families with X-linked inhibitor of apoptosis deficiency and a review of all 26 published cases
J Allergy Clin Immunol
X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis
Clin Immunol
Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG
Blood
Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease
Genet Med
Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency
Cytokine
Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation
Trends Mol Med
Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations
Clin Immunol
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes
Blood
Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis
Blood
Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP
Blood
Inflammasome activation and IL-1beta and IL-18 processing during infection
Trends Immunol
Innate immune control of EBV-infected B cells by invariant natural killer T cells
Blood
Defective acute inflammation in Crohn's disease: a clinical investigation
Lancet
Shigella are versatile mucosal pathogens that circumvent the host innate immune system
Curr Opin Immunol
Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells
Cell
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
Nature
XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP
J Clin Immunol
Advances in understanding the pathogenesis of HLH
Br J Haematol
Familial and acquired hemophagocytic lymphohistiocytosis
Annu Rev Med
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
EMBO Rep
XIAP as a ubiquitin ligase in cellular signaling
Cell Death Differ
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Nature
IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis
Nat Cell Biol
NOD proteins: regulators of inflammation in health and disease
Nat Rev Immunol
Activation of innate immune antiviral responses by Nod2
Nat Immunol
Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication
PLOS ONE
Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells
J Immunol
A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation
EMBO J
XIAP mediates NOD signaling via interaction with RIP2
Proc Natl Acad Sci U S A
The ubiquitin ligase XIAP Recruits LUBAC for NOD2 signaling in inflammation and innate immunity
Mol Cell
Cited by (103)
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
2022, Journal of Allergy and Clinical ImmunologyBalance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases
2022, CytokineCitation Excerpt :A vast majority of patients bearing genetic alterations into the XIAP/BIRC4 gene coding for XIAP evolve to HLH [167,220]. 30–80% of these manifestations are concomitant with EBV infection [221]. In particular, patients display consistently elevated serum IL-18 levels [167].
Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity
2024, Immunological Reviews